Deutsche Bank
HAE icon

Deutsche Bank’s Haemonetics HAE Stock Holding History

Deutsche Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-53,200
Closed -$2.59M – 3665
2025
Q3 		$2.59M Buy
+53,200
New +$3.29M ﹤0.01% 1629
2025
Q1 		– Sell
-14,000
Closed -$1.09M – 3612
2024
Q4 		$1.09M Sell
14,000
-6,000
-30% -$482K ﹤0.01% 2191
2024
Q3 		$1.61M Buy
20,000
+600
+3% +$48.5K ﹤0.01% 1885
2024
Q2 		$1.6M Sell
19,400
-41,700
-68% -$3.67M ﹤0.01% 1745
2024
Q1 		$5.21M Buy
61,100
+31,100
+104% +$2.44M ﹤0.01% 1256
2023
Q4 		$2.57M Sell
30,000
-30,800
-51% -$2.66M ﹤0.01% 1547
2023
Q3 		$5.45M Buy
60,800
+60,722
+77,849% +$5.42M ﹤0.01% 1012
2023
Q2 		$6.64K Buy
+78
New +$6.59K ﹤0.01% 3682
2022
Q2 		– Sell
-64
Closed -$4K – 4203
2022
Q1 		$4K Sell
64
-36
-36% -$1.96K ﹤0.01% 4170
2021
Q4 		$5K Buy
100
+81
+426% +$4.93K ﹤0.01% 4204
2021
Q3 		$1K Buy
+19
New +$1.2K ﹤0.01% 4370

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's HAE Position: Q2 2026 in Review

Deutsche Bank increased its Haemonetics (HAE) stake by 76% in Q2 2026, buying an estimated $17.5M and bringing the position to 631,663 shares worth $47.4M. The position accounts for 0.01% of the portfolio, ranked #665.

Deutsche Bank first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $148M in Q3 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Deutsche Bank held 631,663 shares of Haemonetics worth $47.4M as of Q2 2026.
  • Deutsche Bank bought 272,781 Haemonetics shares in Q2 2026, an estimated $17.5M.
  • Haemonetics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #665 holding.
  • Deutsche Bank first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Haemonetics position peaked at $148M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.